Background: Despite the presence of a strong association between influenza infection and stroke, whether influenza vaccination reduces the risk of stroke is yet a matter of controversy. We conducted a meta-analysis to determine whether influenza vaccination protects against stroke. Methods: We searched PubMed, EMBASE, and the Cochrane Library from database inception date to November 18, 2016, without language restrictions, to identify studies investigating the effect of influenza vaccination on subsequent risk of stroke. We conducted a meta-analysis to quantify the risk of stroke in overall and subgroup analyses and calculated a pooled OR for developing stroke with a 95% CI. Publication bias was assessed by Begg's rank correlation test. Results: Eleven studies fulfilled our inclusion criteria. In a random-effects model, vaccinated individuals had a decreased risk of stroke compared with unvaccinated individuals (OR 0.82; 95% CI 0.75-0.91; p < 0.001). The relationship between influenza vaccination and stroke risk remained robust in subgroup analyses. The significant effect of influenza vaccination was associated with ascertainment of vaccination status and stage of prevention. Conclusion: Vaccination against influenza is associated with a lower risk of stroke. Well-designed prospective studies are needed to provide stronger evidence of the protective effect of influenza vaccination against stroke.

Keywords:
Influenza vaccination, Influenza, Stroke
1.
Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, Ford E, Furie K, Go A, Greenlund K, Haase N, Hailpern S, Ho M, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott M, Meigs J, Mozaffarian D, Nichol G, O'Donnell C, Roger V, Rosamond W, Sacco R, Sorlie P, Stafford R, Steinberger J, Thom T, Wasserthiel-Smoller S, Wong N, Wylie-Rosett J, Hong Y: Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009;119:e21-e181.
2.
Kunst AE, Amiri M, Janssen F: The decline in stroke mortality: exploration of future trends in 7 Western European countries. Stroke 2011;42:2126-2130.
3.
Fugate JE, Lyons JL, Thakur KT, Smith BR, Hedley-Whyte ET, Mateen FJ: Infectious causes of stroke. Lancet Infect Dis 2014;14:869-880.
4.
Liu C, Yavar Z, Sun Q: Cardiovascular response to thermoregulatory challenges. Am J Physiol Heart Circ Physiol 2015;309:H1793-H1812.
5.
Palm F, Dos Santos M, Urbanek C, Greulich M, Zimmer K, Safer A, Grau AJ, Becher H: Stroke seasonality associations with subtype, etiology and laboratory results in the Ludwigshafen Stroke Study (LuSSt). Eur J Epidemiol 2013;28:373-381.
6.
Barnes M, Heywood AE, Mahimbo A, Rahman B, Newall AT, Macintyre CR: Acute myocardial infarction and influenza: a meta-analysis of case-control studies. Heart 2015;101:1738-1747.
7.
Toschke AM, Heuschmann PU, Wood O, Wolfe CD: Temporal relationship between influenza infections and subsequent first-ever stroke incidence. Age Ageing 2009;38:100-103.
8.
Smeeth L, Thomas SL, Hall AJ, Hubbard R, Farrington P, Vallance P: Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 2004;351:2611-2618.
9.
Bermudez-Fajardo A, Oviedo-Orta E: Influenza vaccination promotes stable atherosclerotic plaques in apoE knockout mice. Atherosclerosis 2011;217:97-105.
10.
Udell JA, Zawi R, Bhatt DL, Keshtkar-Jahromi M, Gaughran F, Phrommintikul A, Ciszewski A, Vakili H, Hoffman EB, Farkouh ME, Cannon CP: Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis. JAMA 2013;310:1711-1720.
11.
Grau AJ, Fischer B, Barth C, Ling P, Lichy C, Buggle F: Influenza vaccination is associated with a reduced risk of stroke. Stroke 2005;36:1501-1506.
12.
Nichol KL, Nordin J, Mullooly J, Lask R, Fillbrandt K, Iwane M: Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med 2003;348:1322-1332.
13.
Lavallee P, Perchaud V, Gautier-Bertrand M, Grabli D, Amarenco P: Association between influenza vaccination and reduced risk of brain infarction. Stroke 2002;33:513-518.
14.
Hung IF, Leung AY, Chu DW, Leung D, Cheung T, Chan CK, Lam CL, Liu SH, Chu CM, Ho PL, Chan S, Lam TH, Liang R, Yuen KY: Prevention of acute myocardial infarction and stroke among elderly persons by dual pneumococcal and influenza vaccination: a prospective cohort study. Clin Infect Dis 2010;51:1007-1016.
15.
Pinol-Ripoll G, de la Puerta I, Santos S, Purroy F, Mostacero E: Chronic bronchitis and acute infections as new risk factors for ischemic stroke and the lack of protection offered by the influenza vaccination. Cerebrovasc Dis 2008;26:339-347.
16.
Newall AT, Kelly H, Harsley S, Scuffham PA: Cost effectiveness of influenza vaccination in older adults: a critical review of economic evaluations for the 50- to 64-year age group. Pharmacoeconomics 2009;27:439-450.
17.
Ajani UA, Ford ES, Okoro CA, Strine TW, Giles WH, Mokdad AH: Low prevalence of influenza vaccination among people with cardiovascular disease-BRFSS. Am J Prev Med 2005;29:31-35.
18.
Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB: Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008-2012.
19.
Nicholas JM, Grieve AP, Gulliford MC: Within-person study designs had lower precision and greater susceptibility to bias because of trends in exposure than cohort and nested case-control designs. J Clin Epidemiol 2012;65:384-393.
20.
Lin HC, Chiu HF, Ho SC, Yang CY: Association of influenza vaccination and reduced risk of stroke hospitalization among the elderly: a population-based case-control study. Int J Environ Res Public Health 2014;11:3639-3649.
21.
Katz KA: The (relative) risks of using odds ratios. Arch Dermatol 2006;142:761-764.
22.
Vamos EP, Pape UJ, Curcin V, Harris MJ, Valabhji J, Majeed A, Millett C: Effectiveness of the influenza vaccine in preventing admission to hospital and death in people with type 2 diabetes. CMAJ 2016;188:E342-E351.
23.
Siriwardena AN, Asghar Z, Coupland CC: Influenza and pneumococcal vaccination and risk of stroke or transient ischaemic attack-matched case control study. Vaccine 2014;32:1354-1361.
24.
Lavallee PC, Labreuche J, Fox KM, Lavados P, Mattle H, Steg PG, Amarenco P: Influenza vaccination and cardiovascular risk in patients with recent TIA and stroke. Neurology 2014;82:1905-1913.
25.
Puig-Barbera J, Diez-Domingo J, Varea AB, Chavarri GS, Rodrigo JA, Hoyos SP, Vidal DG: Effectiveness of MF59-adjuvanted subunit influenza vaccine in preventing hospitalisations for cardiovascular disease, cerebrovascular disease and pneumonia in the elderly. Vaccine 2007;25:7313-7321.
26.
Grohskopf LA, Sokolow LZ, Broder KR, Olsen SJ, Karron RA, Jernigan DB, Bresee JS: Prevention and control of seasonal influenza with vaccines. MMWR Recomm Rep 2016;65:1-54.
27.
Phrommintikul A, Kuanprasert S, Wongcharoen W, Kanjanavanit R, Chaiwarith R, Sukonthasarn A: Influenza vaccination reduces cardiovascular events in patients with acute coronary syndrome. Eur Heart J 2011;32:1730-1735.
28.
Jackson ML, Yu O, Nelson JC, Naleway A, Belongia EA, Baxter R, Narwaney K, Jacobsen SJ, Shay DK, Jackson LA: Further evidence for bias in observational studies of influenza vaccine effectiveness: the 2009 influenza A(H1N1) pandemic. Am J Epidemiol 2013;178:1327-1336.
29.
Jackson LA, Jackson ML, Nelson JC, Neuzil KM, Weiss NS: Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol 2006;35:337-344.
30.
Jackson LA, Nelson JC, Benson P, Neuzil KM, Reid RJ, Psaty BM, Heckbert SR, Larson EB, Weiss NS: Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors. Int J Epidemiol 2006;35:345-352.
31.
Mangtani P, Shah A, Roberts JA: Validation of influenza and pneumococcal vaccine status in adults based on self-report. Epidemiol Infect 2007;135:139-143.
32.
Grau AJ, Urbanek C, Palm F: Common infections and the risk of stroke. Nat Rev Neurol 2010;6:681-694.
33.
Naghavi M, Wyde P, Litovsky S, Madjid M, Akhtar A, Naguib S, Siadaty MS, Sanati S, Casscells W: Influenza infection exerts prominent inflammatory and thrombotic effects on the atherosclerotic plaques of apolipoprotein E-deficient mice. Circulation 2003;107:762-768.
34.
Veljkovic V, Glisic S, Veljkovic N, Bojic T, Dietrich U, Perovic VR, Colombatti A: Influenza vaccine as prevention for cardiovascular diseases: possible molecular mechanism. Vaccine 2014;32:6569-6575.
35.
Kunze AK, Annecke A, Wigger F, Lichy C, Buggle F, Schnippering H, Schnitzler P, Grau AJ: Recent infection as a risk factor for intracerebral and subarachnoid hemorrhages. Cerebrovasc Dis 2000;10:352-358.
36.
Roquer J, Cuadrado-Godia E, Giralt-Steinthauer E, Jimena S, Jimenez-Conde J, Martinez-Rodriguez JE, Ois A, Rodriguez-Campello A: Previous infection and stroke: a prospective study. Cerebrovasc Dis 2012;33:310-315.
37.
Simonsen L, Taylor RJ, Viboud C, Miller MA, Jackson LA: Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis 2007;7:658-666.
38.
Kim AS, Johnston SC: Global variation in the relative burden of stroke and ischemic heart disease. Circulation 2011;124:314-323.
39.
Dean AS, Moffatt CR, Rosewell A, Dwyer DE, Lindley RI, Booy R, MacIntyre CR: Incompletely matched influenza vaccine still provides protection in frail elderly. Vaccine 2010;28:864-867.
40.
Asghar Z, Coupland C, Siriwardena N: Influenza vaccination and risk of stroke: self-controlled case-series study. Vaccine 2015;33:5458-5463.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.